Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Haydale Graphene Industries PLC (HAYD)

London
Symbol
Exchange
Currency
HAYDLondonGBP
6HGMunichEUR
6HGFrankfurtEUR
Currency in GBP
Disclaimer
0.440
+0.005(+1.15%)
Closed

HAYD Comments

Haydale (AIM: HAYD), the global technology solutions company, is delighted to announce that it has been shortlisted for The Engineer’s Collaborate to Innovate Awards (C2I) for its work with the Wales Kidney Research Unit (“WKRU”) at Cardiff University on a microRNA sensor for kidney transplant patients.The collaborative team including Haydale, WKRU, Cardiff University Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff University School of Chemistry, Cardiff and Vale University Health Board and University Hospital of Wales are one of six finalists in the Healthcare and Medical Category for The Engineer’s seventh annual C2I Awards.Already a winner of the Kidney Research UK MedTech Competition, the urinary electrochemical microRNA sensor has the potential to replace slower and more costly PCR-based methods for the rapid detection of problems with newly transplanted kidneys. The sensor uses Haydale’s biomedical functionalised graphene ink to accelerate detection without the need for an invasive biopsy.This nomination will support the commercial progress that Haydale is making with its biosensor inks, which have been focused on diabetes monitoring and management. It is anticipated that this will be expanded to wider diagnostics as the technology is adopted.Keith Broadbent, Haydale’s CEO, said he was delighted the team’s hard work had been recognised, commenting:“This is further recognition of our work in healthcare. Our collaboration has helped to accelerate the provision of cutting-edge technological solutions to improve people’s life experience. Using functionalised graphene reduces sensor production time and variability and accelerates translation to improve patient outcomes.
deffo one of the better graphene plays.holding like a baby
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.